Day: October 24, 2019

This week FDA and FTC jointly issued a Warning Letter to another CBD manufacturer for selling CBD as an unapproved drug for pediatric diseases among other claims, and for selling CBD as a dietary supplement. This warning letter is similar to other warning letters issued by FDA in recent years to manufacturers of CBD containing … Read more

Healthcare management apps pose several risks to consumers using them including giving incomplete or incorrect information, providing non-validated instructions for managing a given health condition, failure to respond to health danger, and faulty alarms. This is based on a review of 74 independent clinical studies conducted in the last two years to evaluate the safety … Read more